Literature DB >> 319278

Immunotherapy with viral oncolysates for sarcoma.

J G Sinkovics.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 319278

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  3 in total

1.  Effect of virus-modified tumor cell extracts, autologous mononuclear cell infusions and interleukin-2 on oncolytic activity of effector cells of patients with advanced ovarian cancer.

Authors:  K Furukawa; E Lotzová; R S Freedman; J B Bowen; C L Edwards; J T Wharton
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

2.  Virus-augmented delayed hypersensitivity skin tests in gynecological malignancies.

Authors:  R S Freedman; J M Bowen; E N Atkinson; W Scott; S Wagner
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

3.  Natural killer cell cytotoxic potential of patients with ovarian carcinoma and its modulation with virus-modified tumor cell extract.

Authors:  E Lotzová; C A Savary; R S Freedman; J M Bowen
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.